Sunday, June 28, 2026

Coupang Investors Ask USTR for Trade Relief: Could This Put Toss’s $7B U.S. IPO on Ice in 2026?

U.S. investors are seeking trade relief from South Korea over Coupang losses, impacting local fintech firms' U.S. listing plans.

China-North Korea ‘Anti-US Alliance’ Now Official? Beijing Vows Support in Tariff Wars

China strengthens ties with North Korea after a summit, emphasizing friendship and cooperation during a reception for China's National Day.

North Korea Launches Local Development 20X10 Initiative: What to Expect in 2026?

North Korea's Local Development 20X10 policy initiates construction projects in Panmun district, aiming to boost local welfare and economy.

Tag: Remsima

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Celltrion’s Remsima Surpasses 1 Trillion KRW in Sales for 2nd Consecutive Year: What’s Driving Its Success?

Celltrion's Remsima treatment surpasses 1 trillion KRW in sales, driven by European market growth and new liquid formulation.

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.